Friedhelm Hummel
5
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Non-invasive Deep Brain Stimulation to Improve Spatial Navigation Abilities in Individuals Following Traumatic Brain Injury
Role: lead
Non-invasive Deep Brain Stimulation to Enhance Motor Skill Acquisition in Individuals With Mild Cognitive Impairment
Role: lead
Training in Combination With Non-invasive Brain Stimulation
Role: lead
Plasticity of Deep Brain Structures in Mild Cognitive Impairment and Healthy Aging
Role: lead
Enhancing Sleep Dependent Consolidation by Non-invasive Brain Stimulation
Role: lead
All 5 trials loaded